Abstract
Background Resting state beta band (13 – 30 Hz) oscillations represent pathological neural activity in Parkinson’s disease (PD). It is unknown whether the peak frequency or dynamics of beta oscillations change among rest, fine, limb and axial movements. This will be critical for the development and feasibility of closed loop deep brain stimulation (DBS) algorithms during resting and movement states.
Methods Subthalamic (STN) local field potentials (LFPs) were recorded from a sensing neurostimulator (Activa® PC+S, Medtronic Inc.,) and synchronized to kinematic recordings in twelve PD participants off medication/off STN DBS during thirty seconds of repetitive alternating finger tapping, wrist-flexion extension, stepping in place, and free walking. Beta power peaks and beta burst dynamics were identified by custom algorithms; beta burst dynamics were compared among rest and movement tasks.
Results Resting state burst durations were longer in a PD beta band, which was elevated above the 1/f physiological spectrum compared to an overlapping band (p < 0.001). Beta power peaks were evident during fine, limb, and axial movements in 98% of movement trials; the peak frequencies were similar during movements and at rest. Burst duration, average and peak power were also similar among the four movement tasks across the group but varied within individuals.
Conclusions Prolonged burst durations were a feature of PD bands elevated above and not of PD bands overlapping the 1/f spectrum. The conservation of rest/movement band peak frequency and burst dynamics during different activity states supports the feasibility of successful closed loop DBS algorithms driven by beta burst dynamics during different activities and at rest.
Highlights
Prolonged beta burst durations represent pathological neural activity in Parkinson’s disease
Beta band peak frequencies are similar across rest, fine, limb and axial movements
Beta burst dynamics are similar among rest and different movement states
Conservation of Parkinsonian neural characteristics across different activity states supports the feasibility of closed loop deep brain stimulation systems in daily life
Competing Interest Statement
Helen Bronte-Stewart is a member of the Medtronic Inc. Clinical Advisory Board.
Clinical Trial
NCT02384421
Funding Statement
This work was supported by NINDS Grant 5 R21 NS096398-02, the Parkinson’s Foundation PF-FBS-1899 (to RWA), Michael J. Fox Foundation (9605), Robert and Ruth Halperin Foundation, The Sanches Family Foundation, John A. Blume Foundation and the Helen M. Cahill Award for Research in Parkinson's Disease and Medtronic Inc. provided devices but no financial support.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
The datasets analysed during the current study are available from the corresponding author on reasonable request.